Denali Therapeutics (NASDAQ:DNLI) Price Target Lowered to $28.00 at Bank of America
Denali Therapeutics (NASDAQ:DNLI – Get Free Report) had its target price reduced by Bank of America from $30.00 to $28.00 in ...
Denali Therapeutics (NASDAQ:DNLI) Trading Down 8.9% After Analyst Downgrade
Shares of Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) were down 8.9% during trading on Monday after Bank of America lowered their price target on the stock from $30.00 to $28.00. Bank of ...